Diabetes and Alternative Treatment Models

References (56)

1. 1 International Diabetes Federation 2017 [DOI]
2. 2 Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes [DOI]
3. 3 Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association [DOI]
4. 4 Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables [DOI]
5. 5 The mechanisms of action of metformin [DOI]
6. 6 Epidemiology of Diabetes and Diabetes-Related Complications [DOI]
7. 7 Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management [DOI]
8. 8 Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus [DOI]
9. 9 Diabetes mellitus: The epidemic of the century [DOI]
10. 10 Epidemiology of Type 1 Diabetes [DOI]
11. 11 A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes [DOI]
12. 12 Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study [DOI]
13. 13 Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis [DOI]
14. 14 Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms [DOI]
15. 15 Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention [DOI]
16. 16 A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults [DOI]
17. 17 Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats [DOI]
18. 18 Worldwide childhood type 1 diabetes incidence ? what can we learn from epidemiology? [DOI]
19. 19 Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety [DOI]
20. 20 Diabetes Mellitus Review [DOI]
21. 21 Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus [DOI]
22. 22 Preclinical Evidence for the Pharmacological Actions of Naringin: A Review [DOI]
23. 23 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes [DOI]
24. 24 Seasonal variation of diagnosis of Type 1 diabetes mellitus in children worldwide [DOI]
25. 25 Advanced glycoxidation products and impaired diabetic wound healing [DOI]
26. 26 Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond [DOI]
27. 27 Oral insulin delivery: existing barriers and current counter-strategies [DOI]
28. 28 The accelerating epidemic of childhood diabetes [DOI]
29. 29 Infant feeding and the risk of type 1 diabetes [DOI]
30. 30 Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study [DOI]
31. 31 Treating Type 2 Diabetes Mellitus with Traditional Chinese and Indian Medicinal Herbs [DOI]
32. 32 Diabetic Foot Syndrome as a Possible Cardiovascular Marker in Diabetic Patients [DOI]
33. 33 GLP‐1 receptor agonists vs. DPP‐4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other? [DOI]
34. 34 Blocking AGE-RAGE Signaling Improved Functional Disorders of Macrophages in Diabetic Wound [DOI]
35. 35 Anti-inflammatory and antioxidant effects of polyphenols extracted from Antirhea borbonica medicinal plant on adipocytes exposed to Porphyromonas gingivalis and Escherichia coli lipopolysaccharides [DOI]
36. 36 C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults [DOI]
37. 37 Microgram amounts of abscisic acid in fruit extracts improve glucose tolerance and reduce insulinemia in rats and in humans [DOI]
38. 38 Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes [DOI]
39. 39 Excess Mortality among Persons with Type 2 Diabetes [DOI]
40. 40 Stepwise or Linear Decrease in Penetrance of Type 1 Diabetes With Lower-Risk HLA Genotypes Over the Past 40 Years [DOI]
41. 41 Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis [DOI]
42. 42 Alkaloids in the Nature: Pharmacological Applications in Clinical Practice of Berberine and Mate Tea [DOI]
43. 43 HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform? [DOI]
44. 44 Transcriptomics in type 2 diabetes: Bridging the gap between genotype and phenotype [DOI]
45. 45 Gene therapy in the treatment of autoimmune diseases [DOI]
46. 46 Frequency and Predictors of Self-Reported Hypoglycemia in Insulin-Treated Diabetes [DOI]
47. 47 Pioglitazone-induced congestive heart failure and pulmonary edema in a patient with preserved ejection fraction [DOI]
48. 48 Isoform-specific interactions between meprin metalloproteases and the catalytic subunit of protein kinase A: significance in acute and chronic kidney injury [DOI]
49. 49 Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes [DOI]
50. 50 The Hygiene Hypothesis: An Explanation for the Increased Frequency of Insulin-Dependent Diabetes [DOI]
51. 51 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022 [DOI]
52. 52 Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999 [DOI]
53. 53 Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis [DOI]
54. 54 Meprin Metalloprotease Deficiency Associated with Higher Mortality Rates and More Severe Diabetic Kidney Injury in Mice with STZ-Induced Type 1 Diabetes [DOI]
55. 55 Immunological Monitoring in Beta Cell Replacement: Towards a Pathophysiology-Guided Implementation of Biomarkers [DOI]
56. 56 Complementary and alternative medicine use in self-management of diabetes: A qualitative study of patient and user conversations in online forums [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• First Trimester Fasting Blood Glucose as a Screening Tool for Diabetes Mellitus in a Teaching Hospital Setting in Nigeria — shares topic coverage
• Impact of the Diet Profile and Alcohol Consumption on Cardiometabolic Risks in Dschang Health District-Cameroon — shares topic coverage
• Effect of Aqueous Extract of Persea americana Seed on Blood Glucose in Alloxan-induced Diabetic Wistar Rats — shares topic coverage
• Metal Based α-glucosidase Inhibitors: Synthesis, Characterization and α-glucosidase Inhibition Activity of Transition Metal Complexes — shares topic coverage
• Evaluation of Fluid Therapy by Point-of-Care Ultrasound in Hyperglycemic Emergencies — shares topic coverage